NASDAQ, LXRX - Lexicon Pharmaceutcl

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the  discovery and development of breakthrough treatments for human disease. We use  our proprietary gene knockout technology to knock out, or disrupt, the function  of genes in mice and then employ an integrated platform of advanced medical  technologies to systematically discover the physiological and behavioral  functions of the genes we have knocked out and assess the utility of the  proteins encoded by the corresponding human genes as potential drug targets. For  targets that we believe have high pharmaceutical value, we engage in programs  for the discovery and development of potential small molecule, antibody and  protein drugs. We have advanced four drug candidates into human clinical trials,  with one additional drug candidate in preclinical development and compounds from  a number of additional programs in various stages of preclinical research.  ...

Sector:	Consumer Durables
Industry:	Major Pharmaceuticals
P/E Ratio:	N/A
PEG Ratio:	N/A
EPS:	N/A
DivYield:	N/A
PtB:	2.6578
PtS:	13.1
EBITDA:	N/A
Shares:	363.18M
Market Cap:	392.23M
52wk range:	0.28 - 2.18

216.73.216.229
United States